Gilead Sciences (GILD) Non-Current Deferred Tax Liability (2012 - 2026)

Gilead Sciences (GILD) has 11 years of Non-Current Deferred Tax Liability data on file, last reported at $392.0 million in Q1 2026.

• For the quarter ending Q1 2026, Non-Current Deferred Tax Liability fell 44.71% year-over-year to $392.0 million; the trailing twelve-month figure through Mar 2026 stood at $392.0 million (down 44.71% YoY), and the FY2025 full-year result was $402.0 million, down 44.48% from the prior year.
• Non-Current Deferred Tax Liability for Q1 2026 stood at $392.0 million, down from $402.0 million in the prior quarter.
• Across five years, Non-Current Deferred Tax Liability topped out at $3.7 billion in Q1 2022 and bottomed at $392.0 million in Q1 2026.
• The 5-year median for Non-Current Deferred Tax Liability is $933.0 million (2024), against an average of $1.6 billion.
• The widest annual swing landed in 2022, when Non-Current Deferred Tax Liability dropped 17.41%; it then slumped 61.14% in 2024.
• A 5-year view of Non-Current Deferred Tax Liability shows it stood at $2.7 billion in 2022, then tumbled by 40.59% to $1.6 billion in 2023, then slumped by 54.41% to $724.0 million in 2024, then plunged by 44.48% to $402.0 million in 2025, then dropped by 2.49% to $392.0 million in 2026.
• The last three Non-Current Deferred Tax Liability figures came in at $392.0 million (Q1 2026), $402.0 million (Q4 2025), and $597.0 million (Q3 2025), per Business Quant data.

Peer Comparison